Lactylation-related prognostic signature characterized in pancreatic ductal adenocarcinoma through public scRNA-seq dataset and machine learning algorithms: the TOP2A-H3K18la-NQO1 axis orchestrates malignant progression.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Machine-learning analysis linked pancreatic-cancer lactylation signatures to a specific malignant-progression pathway.
Technology: Methods identify the learned operation enabling the represented result: Machine-learning analysis linked pancreatic-cancer lactylation signatures to a specific malignant-progression pathway.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Methods identify the learned operation enabling the represented result: Machine-learning analysis linked pancreatic-cancer lactylation signatures to a specific malignant-progression pathway.
- Limitation / still unknown
- The reported signature and pathway analysis use existing transcriptomic datasets; the proposed malignant-progression axis remains associative and is not established as causal.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.1038/s41416-026-03477-z · https://europepmc.org/article/MED/42209673
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.